Nom du produit:N-(4-Fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine

IUPAC Name:N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine

CAS:1421372-94-2
Formule moléculaire:C20H16FN5O3
Pureté:95%+
Numéro de catalogue:CM147323
Poids moléculaire:393.38

Unité d'emballage Stock disponible Prix($) Quantité
CM147323-5g in stock Źƿ
CM147323-10g in stock ƿƿƓ
CM147323-25g in stock IJȃǤ
CM147323-100g in stock ƓľǤ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1421372-94-2
Formule moléculaire:C20H16FN5O3
Point de fusion:-
Code SMILES:CN1C=C(C2=NC(NC3=CC([N+]([O-])=O)=C(F)C=C3OC)=NC=C2)C4=C1C=CC=C4
Densité:
Numéro de catalogue:CM147323
Poids moléculaire:393.38
Point d'ébullition:
N° Mdl:MFCD28167946
Stockage:Keep in dark place, store at 2-8°C.

Column Infos

Indoles
Indole is a compound of pyrrole and benzene in parallel, also known as benzopyrrole. There are two combinations of pyrrole and benzene, called indole and isoindole, respectively. Many derivatives of indole have physiological and pharmacological activities, and can synthesize vasodilators, antihistamines, antipyretic analgesics, etc. in medicine, so indole is also a very important heterocyclic compound.
Osimertinib
TAGRISSO (osimertinib) demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial.
TAGRISSO (osimertinib) is a third-generation, irreversible EGFR-TKI with proven clinical activity in NSCLC, including against central nervous system metastases. It is the first and only EGFR TKI recommended by NCCN Guidelines as an adjuvant treatment option for completely resected stage IB-IIIA, stage IIIB (T3, N2) EGFRm (exon 19 deletion, exon 21 L858R mutation) NSCLC.